But when the cells were stimulated with the PAH-promoting growth factor PDGF (Schermuly et al. 2005), an increase in viability was more pronounced in PASMC treated with CM where GRP78 secretion was inhibited. The gene discussed is HSPA5; the disease is pulmonary arterial hypertension.